All Stories

  1. Plasma SH Concentrations and Mortality in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis
  2. Editorial: Advancements in Lung Cancer Precision Oncology Research and Treatments
  3. The prognostic role of inhalation injury in burn patients assessed by flexible bronchoscopy: a systematic review and meta-analysis
  4. Impact of Driver Genetic Alterations on Survival in Metastatic Colorectal Cancer Patients from a Genetically Homogeneous Sardinian Population: A Real-World Study
  5. Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art
  6. KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research
  7. Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma
  8. The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM
  9. Osteopontin in rheumatic diseases: A systematic review and meta-analysis
  10. The impact of multidisciplinary teams on overall mortality and average survival in cancer: a systematic review and meta-analysis
  11. VEGF in psoriatic arthritis: Systematic review and meta-analysis
  12. Circulating Fetuin‐A concentrations in rheumatic diseases: a systematic review and meta‐analysis
  13. Vascular endothelial growth factor in inflammatory bowel disease: A systematic review and meta‐analysis
  14. Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond
  15. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy
  16. Resistin and omentin in breast cancer: A systematic review and meta-analysis
  17. A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus
  18. The association between bilirubin concentrations and inflammatory bowel disease: Insights from a systematic review and meta‐analysis
  19. Role of bronchoscopy in inhalation injury: a case report and literature review
  20. Association between blood Pentraxin‐3 concentrations and rheumatic diseases: A systematic review and meta‐analysis
  21. PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263, SP142 and 22C3 antibodies: A comparative study
  22. Ischemia-Modified Albumin (IMA) Is Associated with Poor Survival in Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF): A Pilot Study
  23. Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma
  24. Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series
  25. Role of Blood Cell Indexes in Progresses to ESRD
  26. Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population
  27. A Systematic Review and Meta-Analysis of Mean Platelet Volume and Platelet Distribution Width in Patients with Obstructive Sleep Apnoea Syndrome
  28. Primary Ewing sarcoma of the lung: A systematic review of the recent literature
  29. Aggregate Index of Systemic Inflammation (AISI), Disease Severity, and Mortality in COVID-19: A Systematic Review and Meta-Analysis
  30. Evaluation of Inflammation and Oxidative Stress Markers in Patients with Obstructive Sleep Apnea (OSA)
  31. PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis
  32. Association between Red Blood Cell Distribution Width and Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis
  33. Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing
  34. Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma
  35. Blood Cells Count Derived Inflammation Indexes as Predictors of Early Treatment Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
  36. Current Trends in Mucosal Melanomas: An Overview
  37. Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
  38. Liquid Biopsy in the Oncological Management of a Histologically Undiagnosed Lung Carcinoma: A Case Report
  39. How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: A minireview
  40. Inflammatory Indexes as Predictive Biomarkers of Postoperative Complications in Oncological Thoracic Surgery
  41. Role of EBUS-TBNA in Non-Neoplastic Mediastinal Lymphadenopathy: Review of Literature
  42. The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis
  43. C reactive protein to albumin ratio (CAR) as predictor of anastomotic leakage in colorectal surgery
  44. INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression
  45. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
  46. Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives
  47. Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
  48. Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation
  49. NGS-Based Analysis of Atypical Deep Penetrating Nevi
  50. Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review
  51. Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy?
  52. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis
  53. The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients
  54. Methodological Fallacies in the Determination of Serum/Plasma Glutathione Limit Its Translational Potential in Chronic Obstructive Pulmonary Disease
  55. Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
  56. Complete blood cell count measures in retinal artey occlusions
  57. SARS-CoV-2 and endothelial cell interaction in COVID-19: molecular perspectives
  58. Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis
  59. Laparoscopic versus Open Transverse-Incision Approach for Right Hemicolectomy: A Systematic Review and Meta-Analysis
  60. Red Blood Cell Distribution Width (RDW) Correlates to the Anatomical Location of Colorectal Cancer. Implications for Clinical Use
  61. Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer
  62. The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients
  63. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
  64. Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease
  65. Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
  66. Diagnostic accuracy of different blood cells-derived indexes in rheumatoid arthritis
  67. Primary Melanoma of the Lung: A Systematic Review
  68. Blood Cell Count Biomarkers, Risk, and Outcomes of Ischemia-Related Lower Limb Amputations: Systematic Review
  69. Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
  70. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis
  71. Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report
  72. Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients
  73. Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art
  74. Mean Platelet Volume, Red Cell Distribution Width, and Complete Blood Cell Count Indices in Retinal Vein Occlusions
  75. Resveratrol Inhibits Oxidative Stress and Prevents Mitochondrial Damage Induced by Zinc Oxide Nanoparticles in Zebrafish (Danio rerio)
  76. Reply
  77. Role of the mTOR pathway in liver cancer: from molecular genetics to targeted therapies
  78. Systemic transsulfuration pathway thiol concentrations in chronic obstructive pulmonary disease patients
  79. Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population
  80. Blood cell count indexes as predictors of anastomotic leakage in elective colorectal surgery: a multicenter study on 1432 patients
  81. Micellar electrokinetic capillary chromatographic determination of pirfenidone and 5-carboxy-pirfenidone by direct injection of plasma from patients receiving treatment for idiopathic pulmonary fibrosis (IPF)
  82. Bilirubin levels in patients with mild and severe Covid‐19: a pooled analysis
  83. Radio-Pathological Correlations in Patients with Liver Metastases for Colorectal Cancer
  84. KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors
  85. In situ reconstruction with autologous graft in the treatment of secondary aortoenteric fistulas: A retrospective case series
  86. Solitary Fibrous Tumor of the Omentum: Presentation of a Case and Literature Review
  87. Long Noncoding RNAs in Non-Small Cell Lung Cancer: State of the Art
  88. Circulating Concentrations of Key Regulators of Nitric Oxide Production in Undernourished Sheep Carrying Single and Multiple Fetuses
  89. Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma
  90. Complete blood cell count indexes in non‐arteritic anterior ischemic optic neuropathy
  91. EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma
  92. Cryoablation In The Management Of Breast Cancer: Evidence To Date
  93. BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas
  94. Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
  95. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study
  96. Diet and melanoma
  97. A diethylpyrocarbonate-based derivatization method for the LC-MS/MS measurement of plasma arginine and its chemically related metabolites and analogs
  98. MALONDIALDEHYDE LEVELS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  99. Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases
  100. Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
  101. Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis
  102. Development of an LC–Tandem Mass Spectrometry Method for the Quantitative Analysis of Hercynine in Human Whole Blood
  103. Hercynine content in widely consumed commercial beverages
  104. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis
  105. Circulating serotonin levels in COPD patients: a pilot study
  106. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis
  107. Red blood cell distribution width in pregnancy: a systematic review
  108. Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
  109. Re: Neutrophil-to-lymphocyte ratio predicts anastomotic dehiscence
  110. Homoarginine and all-cause mortality: A systematic review and meta-analysis
  111. Systemic inflammation indexes predict response to immunotherapy in patients with lung cancer
  112. Coronary flow reserve in systemic rheumatic diseases: a systematic review and meta-analysis
  113. Predictors of hospital stay in thoracic surgery
  114. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review
  115. Markers of oxidative stress, skeletal muscle mass and function, and their responses to resistance exercise training in older adults
  116. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives
  117. Genetic alterations in main candidate genes during melanoma progression
  118. Spontaneous Release of Human Serum Albumin S-Bound Homocysteine in a Thiol-Free Physiological Medium
  119. Vitamin D status and risk for malignant cutaneous melanoma
  120. Female Adnexal Tumors of Probable Wolffian Origin (FATWO)
  121. Predictive Values of C-Reactive Protein and Neutrophil to Lymphocyte Ratio in Detecting Anastomotic Leak in Open Colorectal Surgery
  122. Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
  123. Desmoplastic small round cell tumors of the pleura: a review of the clinical literature
  124. Wirsung Duct Occlusion Versus Pancreaticojejunostomy after Pancreaticoduodenectomy
  125. VATS Thymectomy with 3D Vision: A Chance to Further Improve the Outcomes of Thymus Minimally Invasive Surgery
  126. Mutation analysis of mucosal and cutaneous melanomas during progression.
  127. Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy
  128. Noncoding RNAs in Gallbladder Cancer
  129. Long non-coding RNA CASC2 in human cancer
  130. Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
  131. Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature
  132. Evaluation of Global Genomic DNA Methylation in Human Whole Blood by Capillary Electrophoresis UV Detection
  133. Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
  134. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma
  135. Impact of novel histopathological factors on the outcomes of liver surgery for colorectal cancer metastases
  136. Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
  137. Thoracoscopic treatment of a broncho-esophageal fistula: A case report
  138. Breast Nodular Fasciitis: A Comprehensive Review
  139. Nonfunctional paraganglioma of the head of the pancreas: A rare case report
  140. Small bowel emergencies: two surgical centers’ experience and literature review
  141. Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status
  142. Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from sardinia
  143. Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
  144. Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma
  145. Robotic left ventricular epicardial lead positioning
  146. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway
  147. KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
  148. An unusual case of excessive sweating affecting the right upper limb after bilateral endoscopic thoracic sympathectomy for primary palmar hyperhidrosis: recurrence or compensatory hyperhidrosis?
  149. Discrepant alterations in main candidate genes among multiple primary melanomas
  150. Primär dermales Melanom bei einer Patientin mit multiplen Malignomen in der Vorgeschichte: Ein Fallbericht mit molekularer Charakterisierung
  151. Radiofrequency Ablation in the Management of Advanced Stage Thymomas: A Case Report on a Novel Multidisciplinary Therapeutic Approach
  152. Hybrid transanal endoscopic microsurgery: a novel approach to rectal neoplasm excision
  153. Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
  154. Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: a case report
  155. The “virtual ileostomy” in elective colorectal surgery: is it useful?
  156. Unexpected Distribution ofcKITandBRAFMutations among Southern Italian Patients with Sinonasal Melanoma
  157. Epidemiology of Thyroid Cancer in an Area of Epidemic Thyroid Goiter
  158. Lung cancer epidemiology in North Sardinia, Italy
  159. Impact of Age on the Quality of Lymphadenectomy for Colorectal Cancer
  160. Single access videothoracoscopic biopsy and talc pleurodesis in patients with malignant pleural effusion
  161. Low-Grade Fibromatosis-Like Spindle Cell Metaplastic Carcinoma of the Breast: A Case Report and Literature Review
  162. Warthin-Like Papillary Carcinoma of the Thyroid Gland: Case Report and Review of the Literature
  163. Axillary Lymph Node Dissection in Patients with Breast Cancer and Sentinel Lymph Node Micrometastasis or Isolated Tumor Cells: Is it Necessary?
  164. T2–T4 sympathectomy versus T3–T4 sympathicotomy for palmar and axillary hyperhidrosis